StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury
April 16, 2015 at 08:06 AM EDT
StemCells, Inc. (Nasdaq: STEM), a leading stem cell company developing novel cell-based therapeutics for treating diseases of the ...